Vanillic acid inhibits inflammatory mediators by suppressing NF-κB in lipopolysaccharide-stimulated mouse peritoneal macrophages

References

• Medzhitov, R., Janeway, C.A., Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91, 295–298.
   PubMed Web of Science ®Google Scholar
• Beutler, B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 2000, 12, 20–26.
   PubMed Web of Science ®Google Scholar
• Beutler, B. TNF, immunity and inflammatory disease: lessons of the past decade. J. Investig. Med. 1995, 43, 227–235.
   PubMed Web of Science ®Google Scholar
• Parrillo, J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 1993, 328, 1471–1477.
   PubMed Web of Science ®Google Scholar
• Vane, J.R., Botting, R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 1998, 47, 578–587.
   Web of Science ®Google Scholar
• Morita, I.M., Schindler, M.K., Regier, J.C., Otto, T., Hori, D.L., KeWitt, Smith W.L. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem. 1995, 270, 10902–10908.
   PubMed Web of Science ®Google Scholar
• Otto, J.C., Smith, W.L. Prostaglandin endoperoxide synthases-1 and -2. J. Lipid Mediat. Cell Signal. 1995, 12, 139–156.
   PubMedGoogle Scholar
• MacMicking, J., Xie, Q.W., Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15, 323–350.
   PubMed Web of Science ®Google Scholar
• Pfeilschifter, J., Mühl, H. Immunopharmacology: anti-inflammatory therapy targeting transcription factors. Eur. J. Pharmacol. 1999, 375, 237–245.
   PubMed Web of Science ®Google Scholar
• Sharma, J.N., Al-Omran, A., Parvathy, S.S. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007, 15, 252–259.
   PubMedGoogle Scholar
• Tegeder, I., Pfeilschifter, J., Geisslinger, G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 2001, 15, 2057–2072.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., May, M.J., Kopp, E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16, 225–260.
   PubMed Web of Science ®Google Scholar
• Thanos, D., Maniatis, T. NF-kappa B: a lesson in family values. Cell 1995, 80, 529–532.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P.A., Henkel, T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12, 141–179.
   PubMed Web of Science ®Google Scholar
• Baldwin, A.S., Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14, 649–683.
   PubMed Web of Science ®Google Scholar
• Finco, T.S., Baldwin, A.S. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995, 3, 263–272.
   PubMed Web of Science ®Google Scholar
• Lee, S.H., Stehlik, C., Reed, J.C. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J. Biol. Chem. 2001, 276, 34495–34500.
   PubMed Web of Science ®Google Scholar
• Wang, X., Wang, H., Figueroa, B.E., Zhang, W.H., Huo, C., Guan, Y., Zhang, Y., Bruey, J.M., Reed, J.C., Friedlander, R.M. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington’s disease. J. Neurosci. 2005, 25, 11645–11654.
   PubMed Web of Science ®Google Scholar
• Druilhe, A., Srinivasula, S.M., Razmara, M., Ahmad, M., Alnemri, E.S. Regulation of IL-1beta generation by pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 2001, 8, 649–657.
   PubMed Web of Science ®Google Scholar
• Srinivasula, S.M., Poyet, J.L., Razmara, M., Datta, P., Zhang, Z., Alnemri, E.S. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 2002, 277, 21119–21122.
   PubMed Web of Science ®Google Scholar
• Stehlik, C., Lee, S.H., Dorfleutner, A., Stassinopoulos, A., Sagara, J., Reed, J.C. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J. Immunol. 2003, 171, 6154–6163.
   PubMed Web of Science ®Google Scholar
• Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., Dixit, V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430, 213–218.
   PubMed Web of Science ®Google Scholar
• Jason, G.W., Pajurkova, E.M., Suchowersky, O., Hewitt, J., Hilbert, C., Reed, J., Hayden, M.R. Presymptomatic neuropsychological impairment in Huntington’s disease. Arch. Neurol. 1998, 45, 769–773.
   Google Scholar
• Poyet, J.L., Srinivasula, S.M., Tnani, M., Razmara, M., Fernandes-Alnemri, T., Alnemri, E.S. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 2001, 276, 28309–28313.
   PubMed Web of Science ®Google Scholar
• Faubel, S., Lewis, E.C., Reznikov, L., Ljubanovic, D., Hoke, T.S., Somerset, H., Oh, D.J., Lu, L., Klein, C.L., Dinarello, C.A., Edelstein, C.L. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 2007, 322, 8–15.
   PubMed Web of Science ®Google Scholar
• Lesage-Meessen, L., Delattre, M., Haon, M., Thibault, J.F., Ceccaldi, B.C., Brunerie, P., Asther, M. A two-step bioconversion process for vanillin production from ferulic acid combining Aspergillus niger and Pycnoporus cinnabarinus. J. Biotechnol. 1996, 50, 107–113.
   PubMed Web of Science ®Google Scholar
• Civolani, C., Barghini, P., Roncetti, A.R., Ruzzi, M., Schiesser, A. Bioconversion of ferulic acid into vanillic acid by means of a vanillate-negative mutant of Pseudomonas fluorescens strain BF13. Appl. Environ. Microbiol. 2000, 66, 2311–2317.
   PubMed Web of Science ®Google Scholar
• Duke, J.A. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants. Boca Raton, FL: CRC Press 1992, 999th edition. Available online at: http://www.ars-grin.gov/cgi-bin/duke
   Google Scholar
• Narumi, S., Finke, J.H., Hamilton, T.A. Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J. Biol. Chem. 1990, 265, 7036–7041.
   PubMed Web of Science ®Google Scholar
• Kim, M.S., Lim, W.K., Cha, J.G., An, N.H., Yoo, S.J., Park, J.H., Kim, H.M., Lee, Y.M. The activation of PI 3-K and PKC zeta in PMA-induced differentiation of HL-60 cells. Cancer Lett. 2001, 171, 79–85.
   PubMed Web of Science ®Google Scholar
• Schoonbroodt, S., Legrand-Poels, S., Best-Belpomme, M., Piette, J. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 1997, 321 (Pt 3), 777–785.
   PubMed Web of Science ®Google Scholar
• Kang, K.S., Yokozawa, T., Kim, H.Y., Park, J.H. Study on the nitric oxide scavenging effects of ginseng and its compounds. J. Agric. Food Chem. 2006, 54, 2558–2562.
   PubMed Web of Science ®Google Scholar
• Inbaraj, B.S., Lu, H., Kao, T.H., Chen, B.H. Simultaneous determination of phenolic acids and flavonoids in Lycium barbarum Linnaeus by HPLC-DAD-ESI-MS. J. Pharm. Biomed. Anal. 2010, 51, 549–556.
   PubMed Web of Science ®Google Scholar
• Levites, Y., Weinreb, O., Maor, G., Youdim, M.B., Mandel, S. Green tea polyphenol (−)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 2001, 78, 1073–1082.
   PubMed Web of Science ®Google Scholar
• Gao, X., Xu, Y.X., Janakiraman, N., Chapman, R.A., Gautam, S.C. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol. 2001, 62, 1299–1308.
   PubMed Web of Science ®Google Scholar
• Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S.K., Shishodia, S., Aggarwal, B.B. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol. Pharmacol. 2006, 69, 195–206.
   PubMed Web of Science ®Google Scholar
• Chiang, L.C., Ng, L.T., Chiang, W., Chang, M.Y., Lin, C.C. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 2003, 69, 600–604.
   PubMed Web of Science ®Google Scholar
• Aziz, N.H., Farag, S.E., Mousa, L.A., Abo-Zaid, M.A. Comparative antibacterial and antifungal effects of some phenolic compounds. Microbios 1998, 93, 43–54.
   PubMedGoogle Scholar
• Guimarães, C.M., Gião, M.S., Martinez, S.S., Pintado, A.I., Pintado, M.E., Bento, L.S., Malcata, F.X. Antioxidant activity of sugar molasses, including protective effect against DNA oxidative damage. J. Food Sci. 2007, 72, C039–C043.
   PubMed Web of Science ®Google Scholar
• Kampa, M., Alexaki, V.I., Notas, G., Nifli, A.P., Nistikaki, A., Hatzoglou, A., Bakogeorgou, E., Kouimtzoglou, E., Blekas, G., Boskou, D., Gravanis, A., Castanas, E. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res. 2004, 6, R63–R74.
   PubMed Web of Science ®Google Scholar
• Kim, S.J., Kim, M.C., Um, J.Y., Hong, S.H. The beneficial effect of vanillic acid on ulcerative colitis. Molecules 2010, 15, 7208–7217.
   PubMed Web of Science ®Google Scholar
• Itoh, A., Isoda, K., Kondoh, M., Kawase, M., Kobayashi, M., Tamesada, M., Yagi, K. Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a-induced liver injury. Biol. Pharm. Bull. 2009, 32, 1215–1219.
   PubMed Web of Science ®Google Scholar
• Crofford, L.J., Oates, J.C., McCune, W.J., Gupta, S., Kaplan, M.J., Catella-Lawson, F., Morrow, J.D., McDonagh, K.T., Schmaier, A.H. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases. Arthritis Rheum. 2000, 43, 1891–1896.
   PubMed Web of Science ®Google Scholar
• Meade, E.A., Smith, W.L., DeWitt, D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 1993, 268, 6610–6614.
   PubMed Web of Science ®Google Scholar
• Blackwell, T.S., Christman, J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 1997, 17, 3–9.
   PubMed Web of Science ®Google Scholar
• Tak, P.P., Firestein, G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107, 7–11.
   PubMed Web of Science ®Google Scholar
• Kopp, E., Ghosh, S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994, 265, 956–959.
   PubMed Web of Science ®Google Scholar
• Lappas, M., Permezel, M., Georgiou, H.M., Rice, G.E. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 2002, 67, 668–673.
   PubMed Web of Science ®Google Scholar
• Stark, L.A., Din, F.V., Zwacka, R.M., Dunlop, M.G. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 2001, 15, 1273–1275.
   PubMed Web of Science ®Google Scholar
• Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su, M.S., Flavell, R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995, 267, 2000–2003.
   PubMed Web of Science ®Google Scholar
• Chin, A.I., Dempsey, P.W., Bruhn, K., Miller, J.F., Xu, Y., Cheng, G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002, 416, 190–194.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., Inohara, N., Hernandez, L.D., Galán, J.E., Núñez, G., Janeway, C.A., Medzhitov, R., Flavell, R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416, 194–199.
   PubMed Web of Science ®Google Scholar